Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7.38 USD | -1.60% | -2.45% | -25.75% |
Zusammensetzung des Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
Zu einer Liste hinzufügen 0 ausgewählt |
Kurs
|
%
|
% 5 Tage
|
% 1. Jan.
|
Gewichtung
| |
---|---|---|---|---|---|---|
593 USD | +2.61% | +3.61% | +11.73% | 11,69% | ||
24.46 USD | -1.61% | +3.64% | -19.78% | 11,15% | ||
51.17 USD | -4.44% | -8.45% | -18.26% | 8,55% | ||
21.26 USD | -5.68% | -8.08% | -21.90% | 8,03% | ||
3.54 USD | -3.01% | -6.10% | -38.22% | 6,97% | ||
2.645 USD | -2.40% | -7.84% | -21.28% | 4,87% | ||
5.32 USD | -4.32% | -6.17% | -47.48% | 4,83% | ||
160.8 USD | +0.22% | -1.86% | +3.73% | 4,81% | ||
5.61 USD | -1.92% | +0.36% | -36.68% | 4,71% | ||
6.01 USD | -5.50% | -6.24% | -56.89% | 4,13% | ||
92.32 CHF | +1.97% | +4.94% | +8.78% | 3,79% | ||
0.5614 USD | +7.26% | +1.01% | +3.33% | 3,66% | ||
2.76 USD | -3.50% | -10.10% | -14.02% | 3,54% | ||
149.8 USD | +3.18% | +7.39% | +7.72% | 2,57% | ||
44.94 USD | +0.45% | +2.16% | -12.41% | 2,37% | ||
4.38 USD | -1.24% | -7.98% | +2.58% | 2,23% | ||
94.33 EUR | +1.23% | +3.32% | +5.09% | 2,20% | ||
110.5 USD | -0.74% | -6.27% | -20.62% | 1,77% | ||
422.8 USD | +0.90% | +5.41% | +3.91% | 1,71% | ||
973.8 USD | +0.60% | +1.76% | +10.87% | 1,62% | ||
221.5 USD | -0.56% | +1.83% | -14.40% | 0,65% | ||
Beschreibung
ISIN Code | US48817R7061 |
---|---|
Verwaltungsgebühren | 0.78% |
Anlageklassen | |
Branche | |
Wert | |
Währung | |
Fondsgesellschaft | |
Basiswert | Strategic CRISPR & Gene Editing Technology Index NR - USD |
Merkmale
Gerichtsstand | |
Replikationsmethode | |
Replikationsmodell | |
Erstellungsdatum |
12.01.2022
|
Dividenden-Politik | |
Geographischer Fokus |
Entwicklungen der ausstehenden Beträge ( 31.10.2023 )
Volumen (EUR) | 2 M€ |
---|---|
Volumen 1M | 2 M€ |
Volumen 3M | 2 M€ |
Volumen 6M | 2 M€ |
Volumen 12M | 5 M€ |
- Börse
- ETF
- A3D8U4 ETF
- Einzelwerte Kelly Strategic CRISPR & Gene Editing Technology ETF - USD